Novartis Aktie
99,76
EUR
+1,19
EUR
+1,21
%
91,70
CHF
-0,30
CHF
-0,32
%
Kursziele der Novartis-Aktie in CHF
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Novartis-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 89,00 CHF | -3,42% | 22.07.2025 | |
| UBS AG | 95,00 CHF | +3,09% | 22.07.2025 | |
| DZ BANK | - | - | 18.07.2025 | |
| Goldman Sachs Group Inc. | 95,00 CHF | +3,09% | 18.07.2025 | |
| Deutsche Bank AG | 115,00 CHF | +24,80% | 18.07.2025 | |
| JP Morgan Chase & Co. | 95,00 CHF | +3,09% | 18.07.2025 | |
| Bernstein Research | 115,00 CHF | +24,80% | 17.07.2025 | |
| Jefferies & Company Inc. | 100,00 CHF | +8,52% | 17.07.2025 | |
| Barclays Capital | 85,00 CHF | -7,76% | 21.11.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 0 | 136,58 GBP | +31,94% |
| Bayer | 2 | 7 | 0 | 26,86 EUR | -3,47% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,80 EUR | +56,40% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,14 GBP | +19,78% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 163,50 EUR | +50,00% |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +8,25% |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +16,03% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 274,38 CHF | +7,98% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 113,12 EUR | +37,21% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |